Cap table 101: navigating equity and dilution

What is a cap table and why it matters

Your capitalization table—or "cap table"—is arguably the most important document in your startup. It's a spreadsheet that shows exactly who owns what percentage of your company. Every founder, investor, employee with stock options, and anyone else with an equity stake appears on this document with precise ownership percentages.

Many early-stage founders treat the cap table as an afterthought, something to deal with "later." That's a mistake. Your cap table determines everything: who has voting power, who receives distributions, who can block major decisions, and ultimately, how much money you pocket in an acquisition or IPO.

A poorly managed cap table can lead to deadlock between co-founders, dilution that leaves you with a negligible stake, or legal disputes that consume time and capital you don't have. Conversely, understanding your cap table deeply means you can make informed fundraising decisions, negotiate better terms, and protect your interests long-term.

Key components of a cap table

Before diving into fundraising rounds and dilution, you need to understand what actually appears on a cap table. Let's break down the key components:

Common Stock

This is typically what founders and early employees receive. Common stockholders have voting rights but come last in the liquidation waterfall—meaning they only get paid after preferred stockholders and creditors. If your startup fails and gets acquired for less than the investors' preference stack requires, common stockholders get nothing.

Preferred Stock

Investors (VCs, angels, corporate partners) typically receive preferred stock with special rights. Preferred shareholders often have liquidation preferences (they get paid first), anti-dilution protections, board seats, and other governance rights. There are multiple series—Series A, Series B, Series C—each potentially with different terms.

Stock Options

You reserve a pool of shares (typically 10-20% of fully-diluted equity) to offer employees. These aren't issued immediately; instead, employees receive options that vest over time (commonly four years with a one-year cliff). When an employee exercises their options, they buy shares at the strike price, which is typically set at the fair market value on the grant date.

SAFEs (Simple Agreements for Future Equity)

Created by Y Combinator, a SAFE is a convertible security that's not technically a stock. It's simpler and cheaper than a preferred stock round, making it ideal for seed-stage fundraising. SAFEs convert to preferred stock during a future funding round at a discount to that round's price, rewarding early investors. Good Combinator, for instance, invests $150K via SAFE, which typically converts at a 7% equity stake in your next qualifying funding round.

Convertible Notes

These are debt instruments with a conversion feature. You borrow money from investors with the agreement that their loan converts to equity at a future funding event, usually a Series A. Convertible notes have maturity dates (typically 18-24 months) and interest rates, adding pressure to raise a "real" round before maturity.

How dilution works: round by round

Dilution is the process where your ownership percentage decreases as new shares are issued. Let's walk through a concrete example that shows how a founder's stake evolves from seed to Series B:

The Example: TechStartup Inc.

Initial Cap Table (Pre-Seed):

• Founder A: 5,000,000 shares (50%)
• Founder B: 5,000,000 shares (50%)
• Employee Option Pool: 0 shares (reserved, not yet issued)
• Total Outstanding: 10,000,000 shares

Seed Round ($1M via SAFE):

An angel investor and Good Combinator together invest $1M via SAFEs with a 7% discount and $5M post-money valuation cap. You don't issue new shares yet—SAFEs are just promises to convert later.

• Founder A: 5,000,000 shares (50% of common stock)
• Founder B: 5,000,000 shares (50% of common stock)
• SAFEs Outstanding: $1M (not yet equity)
• Total Outstanding Common: 10,000,000 shares

Series A ($5M raise, $15M post-money valuation):

Your SAFEs convert to Series A preferred stock. At a $15M post-money valuation with a 7% discount, they convert at ~$6.5/share (7% discount to the $7/share Series A price). Your SAFEs convert to roughly 153,846 Series A shares (assuming $1M ÷ $6.5/share).

The Series A investor gets $5M of new preferred stock at $7/share = 714,286 Series A shares.

Total new shares issued: ~868,132 (SAFEs converted + Series A shares)

• Founder A: 5,000,000 common shares (30.9% of post-Series A total of 16,168,132)
• Founder B: 5,000,000 common shares (30.9%)
• SAFE Investors (converted): 153,846 Series A preferred shares (0.9%)
• Series A Investor: 714,286 Series A preferred shares (4.4%)
• Employee Option Pool: 1,300,000 shares reserved (8%)
• Total Fully Diluted: 16,168,132 shares

Key Observation: Each founder was diluted from 50% to ~30.9%, but this is expected and healthy. You raised capital to accelerate growth, and investors accepted meaningful dilution to help you succeed.

Series B ($10M raise, $40M post-money valuation):

The Series B investor gets $10M at $10/share (based on the $40M post-money valuation), equaling 1,000,000 Series B shares.

• Founder A: 5,000,000 common shares (11.4% of ~43.9M fully diluted)
• Founder B: 5,000,000 common shares (11.4%)
• SAFE Investors: 153,846 Series A (0.35%)
• Series A Investor: 714,286 Series A (1.6%)
• Series B Investor: 1,000,000 Series B (2.3%)
• Employee Option Pool: 3,500,000 shares (8%)
• Total Fully Diluted: ~43,868,132 shares

The Dilution Takeaway: From 50% → 30.9% → 11.4%. Your percentage ownership declines significantly, but the company's valuation is now $40M versus initial $5M—your actual stake is worth far more. This is why founders accept dilution: the pie grows faster than your slice shrinks.

Cap table best practices for early-stage founders

1. Keep Your Cap Table Updated Religiously — Every SAFE, equity grant, option pool adjustment, and stock split should be recorded. Many founders let their cap table become stale, leading to disputes and confusion later. Use a spreadsheet or cap table management tool and update it immediately after any equity event.

2. Document Everything in Writing — Stock option grants, co-founder equity splits, and investor agreements should all be memorialized in written documents signed by authorized company representatives. Handshake deals on equity lead to heartbreak.

3. Establish a Clear Option Pool — Most investors expect you to have reserved 10-20% of fully-diluted shares for employee options. If you haven't reserved this upfront, you'll dilute founders and existing investors when you eventually grant options, creating friction. Think about your hiring plan 3-5 years out and reserve accordingly.

4. Understand Anti-Dilution Mechanics — Some preferred investors have "full-ratchet" anti-dilution (their conversion price drops to match a future down round), while others have "weighted-average" anti-dilution (a more moderate adjustment). Full-ratchet is brutal for founders; negotiate weighted-average or carve-outs if possible.

5. Negotiate Board Seat Rights Carefully — Investors often demand board seats. Make sure you understand voting agreements and board composition. Too many investor board members can hamstring your decision-making.

6. Plan Your Equity Grants for Employees — Don't grant options haphazardly. Create a consistent framework: what does an engineer at year-one get? A VP of Sales? Consistency reduces friction and signals professionalism to prospective hires.

Common mistakes that haunt founders later

Mistake 1: Unequal Founder Splits Without Documentation

Two founders start a company. One assumes 50-50. The other worked elsewhere part-time for the first year. Years later, during a Series A, lawyers discover no written equity agreement, and a painful re-negotiation ensues. Lock in your founder split in writing, even if it's not yet 50-50. If roles change, amend the agreement.

Mistake 2: Oversized Option Pools

You reserve 30% for employee options thinking you'll hire aggressively. Series A investors see this, realize 30% of the cap table is reserved but unvested, and either demand the pool be reduced (diluting founders) or heavily discount their valuation because of the overhang. Reserve 10-20% unless you have a specific hiring plan justifying more.

Mistake 3: Accepting Bad Anti-Dilution Terms Without Negotiation

Full-ratchet anti-dilution looks minor in the term sheet but can be devastating if you hit a down round. A Series A at $10/share with full-ratchet anti-dilution means if Series B prices at $5/share, Series A's conversion price resets to $5, and they effectively get double the shares. This dilutes founders massively. Push for weighted-average anti-dilution or exclude small equity raises from triggering anti-dilution.

Mistake 4: Ignoring Liquidation Preferences

Your Series A investors might have a 1x non-participating preferred with a liquidation preference. This seems benign, but if your company exits for $20M and Series A invested $5M, Series A gets their $5M back first, and the remaining $15M is split among common stockholders (founders and employees). A 2x preference means they get $10M first, and you get much less. Understand these deeply.

Mistake 5: Not Planning for Secondary Sales or Buybacks

If an early employee's shares vest but the company hasn't gone public, they may want to sell their shares for liquidity. If you don't have a secondary market or buyback plan, they may become hostile. Plan for this, especially for your own equity—sometimes you need to take a small secondary sale to buy a house or diversify.

Tools for managing your cap table

Carta — The industry standard for cap table management. Carta automates equity tracking, handles multiple financing rounds, manages option pools, and integrates with your legal docs. Pricing scales with your company size. Most Series A+ companies use Carta.

Pulley — A newer, founder-friendly alternative to Carta with a focus on simplicity and automation. Pulley handles SAFEs, convertible notes, stock options, and full cap table management. Good for early-stage companies transitioning into their first institutional round.

Spreadsheets — Honest truth: many early-stage startups use a well-organized Excel or Google Sheets with clear columns for investor name, shares, class of stock, price per share, and fully-diluted calculations. If you keep it updated and consistent, a spreadsheet works fine until Series A. Use one of the templates from Y Combinator or Techstars as a starting point.

Your Lawyer — This isn't a tool, but every cap table decision—especially before institutional rounds—should be reviewed by a securities attorney. They catch anti-dilution clauses, board seat implications, and other legal issues that spreadsheets won't flag. The cost ($1-5K) is far less than the problems a bad cap table structure creates.

Good Combinator's terms: $150K for 7% equity via SAFE

At Good Combinator, we invest $150K in early-stage companies via a SAFE with a 7% target equity stake at the next qualifying funding round. Here's what that means for you:

What You Get: $150K in capital—no debt, no interest, no repayment obligation. The money is yours to spend on product, hiring, or growth.

The SAFE Mechanism: Your SAFE converts to Series A preferred stock (or a future Series A equivalent) at the next qualifying round. SAFEs are intentionally simple—no board seat, no governance rights, no liquidation preference. SAFEs are pro-founder in that respect.

The 7% Target: We aim for a 7% equity stake, but this is calculated at conversion. If your Series A values the company at $21.4M post-money, our $150K converts at a discount rate that nets us approximately 7%. The exact percentage depends on your Series A valuation and the SAFE's MFN (most-favored-nation) clause and pro-rata rights.

Why This Works for Founders: SAFEs are lightweight. You don't give up board seats, and your cap table remains simple. If you don't raise a Series A for 5 years, your SAFE just sits there—no interest accrual, no maturity date, no pressure. The money is dilutive (you're giving up 7% of future equity), but the cost is lower than a traditional preferred stock round or convertible note with interest.

For more details on Good Combinator's investment process and terms, visit our application page or check our FAQ.

Key takeaways

• Your cap table is a crucial legal and financial document. Keep it updated, organized, and reviewed by counsel.
• Dilution is inevitable and healthy during growth, but understand exactly how each round affects your ownership percentage and total value.
• Different equity instruments (common stock, preferred stock, SAFEs, options, convertible notes) have different rights and implications. Know the differences before you sign anything.
• Many common cap table mistakes (bad anti-dilution, oversized option pools, unclear founder splits) can be avoided with upfront planning and documentation.
• Use cap table management tools like Carta or Pulley to scale beyond spreadsheets, and always consult a securities attorney before major equity events.
• SAFEs are an excellent instrument for early-stage founders, offering simplicity and founder-friendly terms without board seats or interest accrual.

Your cap table is the legal foundation of your company's equity structure. Take it seriously, update it consistently, and don't hesitate to ask questions or seek counsel from experienced founders or lawyers. The small effort you invest in cap table discipline now will pay dividends when it comes time to raise capital, hire key executives, or eventually exit.